Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
On 23-24 July 2026, the US Food and Drug Administrations Pharmacy Compounding Advisory Committee recommended that six of seven peptides it assessed (BPC-157, KPV, TB-500,MOTS-c, epitalon and semax) be considered for inclusion on the section 503A Bulks List, potentially permitting their use in patient-specific compounded preparations.[2,7] The votes were close and advisory
Continue for 16 to 24 weeks minimum before assessing results
Dosage: 300-500 mcg daily via subcutaneous injection
It is an exciting frontier in medicine that offers a proactive approach to aging and wellness
BPC-157 10mg | Research Peptide
For Canadian researchers, the operating reality in 2026 is a tightening Health Canada enforcement environment combined with a demanding documentation standard for any laboratory material
US$ 21.73
US$ 20.37
.png)
US$ 29.33
US$ 29.45
US$ 25.70
